Sustained improvement of cognition and global function in patients with moderately severe Alzheimer’s disease:a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin®
Keyword(s):
1998 ◽
Vol 158
(9)
◽
pp. 1021
◽
Keyword(s):
Keyword(s):
2006 ◽
Vol 175
(4S)
◽
pp. 34-34
◽
Keyword(s):
2007 ◽
Vol 2007
◽
pp. 242-243
Keyword(s):
2006 ◽
Vol 2006
◽
pp. 93-95